サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1769687

オンコセルカ症治療の世界市場レポート2025年

Onchocerciasis Treatment Global Market Report 2025

出版日
ページ情報
英文 175 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
オンコセルカ症治療の世界市場レポート2025年
出版日: 2025年07月07日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

オンコセルカ症治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.5％で14億8,000万米ドルに成長します。予測期間の成長は、流行地域における有病率の上昇、外科手術に対する需要の高まり、ヘルスケアインフラの拡大、慢性疾患の有病率の増加、ヘルスケア投資の増加などの要因によるものです。予測期間における主要動向としては、単回投与レジメンへの移行、大環状ラクトン製剤の進歩、ウォルバキア菌標的治療の出現、創薬における人工知能（AI）の統合、小児に特化した治療法の開発などが挙げられます。

眼に関連する疾患に罹患する人の増加は、オンコセルカ症治療市場の成長を促進すると予想されます。これらの疾患には、感染症、けが、緑内障や白内障などの慢性疾患など、さまざまな視力や眼の健康問題が含まれます。この増加の主要因は、スクリーン時間の延長とデジタル機器への長時間の接触です。オンコセルカ症治療は、炎症や眼球損傷の原因となる寄生虫感染を除去することで、視力低下の予防と管理に重要な役割を果たします。例えば、2024年5月、米国疾病予防管理センター（CDC）によると、40歳以上のアメリカ人のうち、少なくとも片目に白内障を患っている人は約2,050万人で、この年齢層の17.2％に相当します。この数は2028年までに3,000万人近くに達すると予想されています。その結果、目に関連する問題の有病率の増加がオンコセルカ症治療の需要を押し上げています。

外科手術のニーズの高まりもオンコセルカ症治療市場の成長に寄与しています。外科的処置は、疾患によって影響を受けた組織を除去または修復するための医療介入を含み、薬剤治療が失敗した場合や合併症が長期的な健康リスクをもたらす場合に必要とされることが多いです。一部の患者ではオンコセルカ症が進行しているため、視力低下や外見の醜さといった永久的な損傷を防ぐために外科的介入が必要となります。これに対応するため、ヘルスケアシステムは外科手術能力を強化し、先進的技術を採用することで、市場の拡大を支えています。例えば、2024年6月、国際美容整形外科学会（ISAPS）は、2023年に世界で約3,500万件の美容整形手術が行われ、前年比3.4％増を記録したと報告しました。外科手術は5.5％増加し、1,580万件以上が形成外科医によって行われました。このような手術需要の高まりは、オンコセルカ症治療市場を強化しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、コロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界のオンコセルカ症治療：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
  • 最終用途産業の分析
  • 世界のオンコセルカ症治療市場：成長率分析
  • 世界のオンコセルカ症治療市場の実績：規模と成長、2019～2024年
  • 世界のオンコセルカ症治療市場の予測：規模と成長、2024～2029年、2034年
  • 世界のオンコセルカ症治療：総潜在市場規模（TAM）

第6章 市場セグメンテーション

  • 世界のオンコセルカ症治療市場：薬剤タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • イベルメクチン
  • ドキシサイクリン
  • アルベンダゾール
  • モキシデクチン
  • 世界のオンコセルカ症治療市場：治療戦略別、実績と予測、2019～2024年、2024～2029年、2034年
  • 集団薬剤投与（MDA）
  • 標的治療
  • 世界のオンコセルカ症治療市場：投与方法別、実績と予測、2019～2024年、2024～2029年、2034年
  • 経口
  • 注射
  • 局所
  • 世界のオンコセルカ症治療市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • 世界のオンコセルカ症治療市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
  • 病院とクリニック
  • 在宅ケア
  • 政府と非政府プログラム
  • 世界のオンコセルカ症治療市場、イベルメクチンのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 経口錠
  • コミュニティベースの集団薬剤投与（MDA）キット
  • 固定用量併用療法
  • 小児用製剤
  • 世界のオンコセルカ症治療市場、ドキシサイクリンのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 経口カプセル
  • 徐放錠
  • 抗ボルバキア療法との併用
  • 病院での処方薬による治療
  • 世界のオンコセルカ症治療市場、アルベンダゾールのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 単回服用経口錠
  • イベルメクチンとの併用療法
  • 政府が提供する予防化学療法包装
  • 流行地域における市販薬（OTC）製剤
  • 世界のオンコセルカ症治療市場、モキシデクチンのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 経口錠
  • 長時間作用型製剤
  • 成人のみの投与レジメン
  • 臨床検査によるアクセスプログラム

第7章 地域別・国別分析

  • 世界のオンコセルカ症治療市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
  • 世界のオンコセルカ症治療市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • オンコセルカ症治療市場：競合情勢
  • オンコセルカ症治療市場：企業プロファイル
    • Merck & Co. Inc.
    • Teva Pharmaceutical Industries Limited
    • Hetero Labs Limited
    • Sun Pharmaceutical Industries Limited
    • Intas Pharmaceuticals Limited

第31章 その他の大手企業と革新的企業

  • Dr. Reddy's Laboratories Inc.
  • Cipla Limited
  • Endo Inc.
  • Lupin Limited
  • Instituto de Tecnologia em Imunobiologicos Bio-Manguinhos-Fundacao Oswaldo Cruz（Fiocruz）
  • AMGIS Lifescience Ltd.
  • Drugs for Neglected Diseases initiative（DNDi）
  • Rakshit Drugs Pvt. Ltd.
  • Hangzhou Longshine Bio-Tech Co. Ltd.
  • OREX Pharma Private Limited
  • Angle Bio Pharma Pvt. Ltd.
  • Senores Pharmaceuticals Inc.
  • Avenacy LLC
  • Dolphin Pharma
  • Cerata Pharmaceuticals Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

  • オンコセルカ症治療市場、2029年：新たな機会を提供する国
  • オンコセルカ症治療市場、2029年：新たな機会を提供するセグメント
  • オンコセルカ症治療市場、2029年：成長戦略
    • 市場動向による戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r36002

Onchocerciasis treatment encompasses medical and therapeutic interventions aimed at managing and eliminating infections caused by Onchocerca volvulus, the parasite responsible for river blindness-a disease that primarily impacts the skin and eyes. The key objective of treatment is to eradicate the microfilariae (immature larvae) to reduce transmission, alleviate symptoms, and lower the risk of vision impairment.

The primary drugs used in onchocerciasis treatment include ivermectin, doxycycline, albendazole, and moxidectin. Ivermectin is an antiparasitic agent employed in treating several parasitic diseases, including onchocerciasis (river blindness), by targeting and killing the parasite's larvae (microfilariae). Treatment approaches consist of mass drug administration (MDA) and targeted therapies, utilizing various forms of administration such as oral, injectable, and topical options. These treatments are distributed through hospital pharmacies, retail pharmacies, and online platforms, and they cater to end-users including hospitals and clinics, home-based care settings, and government as well as non-governmental initiatives.

The onchocerciasis treatment market research report is one of a series of new reports from The Business Research Company that provides onchocerciasis treatment market statistics, including the onchocerciasis treatment industry global market size, regional shares, competitors with the onchocerciasis treatment market share, detailed onchocerciasis treatment market segments, market trends, opportunities, and any further data you may need to thrive in the onchocerciasis treatment industry. This onchocerciasis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The onchocerciasis treatment market size has grown strongly in recent years. It will grow from $1.03 billion in 2024 to $1.11 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period is due to an increase in patients suffering from eye-associated issues, an increase in parasitic infections, an increase in the number of targeted treatment centers, a rise in education campaigns, and an increase in the geriatric population.

The onchocerciasis treatment market size is expected to see strong growth in the next few years. It will grow to $1.48 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period is due to factors such as rising prevalence in endemic regions, rising demand for surgical procedures, expanding healthcare infrastructure, growing prevalence of chronic diseases, and increasing healthcare investments. Major trends in the forecast period include a shift towards single-dose regimens, advancements in macrocyclic lactone formulations, the emergence of Wolbachia-targeting therapies, the integration of artificial intelligence (AI) in drug discovery, and the development of pediatric-specific treatments.

The increasing number of individuals suffering from eye-related conditions is expected to drive the growth of the onchocerciasis treatment market. These conditions encompass a range of vision and ocular health issues, including infections, injuries, and chronic diseases such as glaucoma and cataracts. A key contributor to this rise is the extended screen time and prolonged exposure to digital devices. Onchocerciasis treatment plays a crucial role in preventing and managing vision loss by eliminating the parasitic infection responsible for inflammation and ocular damage. For example, in May 2024, the Centers for Disease Control and Prevention (CDC) reported that approximately 20.5 million Americans over the age of 40 have cataracts in at least one eye, representing 17.2% of that age group. The number is expected to reach nearly 30 million by 2028. Consequently, the growing prevalence of eye-related issues is boosting the demand for onchocerciasis treatment.

The increasing need for surgical procedures is also contributing to the growth of the onchocerciasis treatment market. Surgical procedures involve medical interventions to remove or repair tissues affected by disease and are often required when drug treatments fail or complications pose long-term health risks. The progression of onchocerciasis to advanced stages in some patients necessitates surgical intervention to prevent permanent damage such as vision loss or disfigurement. In response, healthcare systems are enhancing their surgical capabilities and adopting advanced techniques, thereby supporting market expansion. For instance, in June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS) reported that nearly 35 million aesthetic procedures were performed globally in 2023, marking a 3.4% increase from the previous year. Surgical procedures rose by 5.5%, with more than 15.8 million performed by plastic surgeons. This growing demand for surgeries is reinforcing the onchocerciasis treatment market.

Leading companies in the onchocerciasis treatment market are prioritizing the development of innovative antiparasitic drugs to enhance treatment outcomes and accessibility. These drugs target parasites such as worms and protozoa, which are responsible for infections like onchocerciasis. In December 2024, Medicines Development for Global Health (MDGH), an Australian non-profit biopharmaceutical company, received approval from the Ghana Food and Drugs Authority for Moxidectin 2 mg oral tablets, intended for the treatment of river blindness in individuals aged four and above. This approval paves the way for community-wide mass drug administration initiatives in Ghana, utilizing moxidectin's superior efficacy and extended duration of action compared to ivermectin. Through this initiative, MDGH aims to increase access to a more effective treatment, supporting widespread implementation in endemic areas.

Major players in the onchocerciasis treatment market are Merck & Co. Inc., Teva Pharmaceutical Industries Limited, Hetero Labs Limited, Sun Pharmaceutical Industries Limited, Intas Pharmaceuticals Limited, Dr. Reddy's Laboratories Inc., Cipla Limited, Endo Inc., Lupin Limited, Instituto de Tecnologia em Imunobiologicos Bio-Manguinhos - Fundacao Oswaldo Cruz (Fiocruz), AMGIS Lifescience Ltd., Drugs for Neglected Diseases initiative (DNDi), Rakshit Drugs Pvt. Ltd., Hangzhou Longshine Bio-Tech Co. Ltd., OREX Pharma Private Limited, Angle Bio Pharma Pvt. Ltd., Senores Pharmaceuticals Inc., Avenacy LLC, Dolphin Pharma, and Cerata Pharmaceuticals Inc.

North America was the largest region in the onchocerciasis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in onchocerciasis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the onchocerciasis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The onchocerciasis treatment market consists of revenues earned by entities providing services such as mass drug administration (MDA) campaigns, community-based health outreach, disease surveillance and diagnostics, vector control initiatives, and public health education. The market value includes the value of related goods sold by the service provider or included within the service offering. The onchocerciasis treatment market also includes sales of antiparasitic drugs, diagnostic kits, drug delivery tools, and protective supplies. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Onchocerciasis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on onchocerciasis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for onchocerciasis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The onchocerciasis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Drug Type: Ivermectin; Doxycycline; Albendazole; Moxidectin
  • 2) By Treatment Strategy: Mass Drug Administration (MDA); Targeted Treatment
  • 3) By Mode Of Administration: Oral; Injectables; Topical
  • 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
  • 5) By End User: Hospitals And Clinics; Home Care Settings; Government And Non-Governmental Programs
  • Subsegments:
  • 1) By Ivermectin: Oral Tablets; Community-Based Mass Drug Administration (MDA) Kits; Fixed-Dose Combination Therapies; Pediatric Formulations
  • 2) By Doxycycline: Oral Capsules; Extended-Release Tablets; Combination With Anti-Wolbachia Therapy; Hospital-Based Prescription Treatments
  • 3) By Albendazole: Single-Dose Oral Tablets; Combination Therapy With Ivermectin; Government-Supplied Preventive Chemotherapy Packages; Over-The-Counter (OTC) Formulations In Endemic Areas
  • 4) By Moxidectin: Oral Tablets; Long-Acting Formulations; Adult-Only Dosing Regimens; Clinical Trial-Based Access Programs
  • Companies Mentioned: Merck & Co. Inc.; Teva Pharmaceutical Industries Limited; Hetero Labs Limited; Sun Pharmaceutical Industries Limited; Intas Pharmaceuticals Limited
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Onchocerciasis Treatment Market Characteristics

3. Onchocerciasis Treatment Market Trends And Strategies

4. Onchocerciasis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Onchocerciasis Treatment Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Onchocerciasis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Onchocerciasis Treatment Market Growth Rate Analysis
  • 5.4. Global Onchocerciasis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Onchocerciasis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Onchocerciasis Treatment Total Addressable Market (TAM)

6. Onchocerciasis Treatment Market Segmentation

  • 6.1. Global Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ivermectin
  • Doxycycline
  • Albendazole
  • Moxidectin
  • 6.2. Global Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mass Drug Administration (MDA)
  • Targeted Treatment
  • 6.3. Global Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral
  • Injectables
  • Topical
  • 6.4. Global Onchocerciasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • 6.5. Global Onchocerciasis Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Home Care Settings
  • Government And Non-Governmental Programs
  • 6.6. Global Onchocerciasis Treatment Market, Sub-Segmentation Of Ivermectin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral Tablets
  • Community-Based Mass Drug Administration (MDA) Kits
  • Fixed-Dose Combination Therapies
  • Pediatric Formulations
  • 6.7. Global Onchocerciasis Treatment Market, Sub-Segmentation Of Doxycycline, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral Capsules
  • Extended-Release Tablets
  • Combination With Anti-Wolbachia Therapy
  • Hospital-Based Prescription Treatments
  • 6.8. Global Onchocerciasis Treatment Market, Sub-Segmentation Of Albendazole, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Dose Oral Tablets
  • Combination Therapy With Ivermectin
  • Government-Supplied Preventive Chemotherapy Packages
  • Over-The-Counter (OTC) Formulations In Endemic Areas
  • 6.9. Global Onchocerciasis Treatment Market, Sub-Segmentation Of Moxidectin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral Tablets
  • Long-Acting Formulations
  • Adult-Only Dosing Regimens
  • Clinical Trial-Based Access Programs

7. Onchocerciasis Treatment Market Regional And Country Analysis

  • 7.1. Global Onchocerciasis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Onchocerciasis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Onchocerciasis Treatment Market

  • 8.1. Asia-Pacific Onchocerciasis Treatment Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Onchocerciasis Treatment Market

  • 9.1. China Onchocerciasis Treatment Market Overview
  • 9.2. China Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Onchocerciasis Treatment Market

  • 10.1. India Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Onchocerciasis Treatment Market

  • 11.1. Japan Onchocerciasis Treatment Market Overview
  • 11.2. Japan Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Onchocerciasis Treatment Market

  • 12.1. Australia Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Onchocerciasis Treatment Market

  • 13.1. Indonesia Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Onchocerciasis Treatment Market

  • 14.1. South Korea Onchocerciasis Treatment Market Overview
  • 14.2. South Korea Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Onchocerciasis Treatment Market

  • 15.1. Western Europe Onchocerciasis Treatment Market Overview
  • 15.2. Western Europe Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Onchocerciasis Treatment Market

  • 16.1. UK Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Onchocerciasis Treatment Market

  • 17.1. Germany Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Onchocerciasis Treatment Market

  • 18.1. France Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Onchocerciasis Treatment Market

  • 19.1. Italy Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Onchocerciasis Treatment Market

  • 20.1. Spain Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Onchocerciasis Treatment Market

  • 21.1. Eastern Europe Onchocerciasis Treatment Market Overview
  • 21.2. Eastern Europe Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Onchocerciasis Treatment Market

  • 22.1. Russia Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Onchocerciasis Treatment Market

  • 23.1. North America Onchocerciasis Treatment Market Overview
  • 23.2. North America Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Onchocerciasis Treatment Market

  • 24.1. USA Onchocerciasis Treatment Market Overview
  • 24.2. USA Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Onchocerciasis Treatment Market

  • 25.1. Canada Onchocerciasis Treatment Market Overview
  • 25.2. Canada Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Onchocerciasis Treatment Market

  • 26.1. South America Onchocerciasis Treatment Market Overview
  • 26.2. South America Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Onchocerciasis Treatment Market

  • 27.1. Brazil Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Onchocerciasis Treatment Market

  • 28.1. Middle East Onchocerciasis Treatment Market Overview
  • 28.2. Middle East Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Onchocerciasis Treatment Market

  • 29.1. Africa Onchocerciasis Treatment Market Overview
  • 29.2. Africa Onchocerciasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Onchocerciasis Treatment Market, Segmentation By Treatment Strategy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Onchocerciasis Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Onchocerciasis Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Onchocerciasis Treatment Market Competitive Landscape
  • 30.2. Onchocerciasis Treatment Market Company Profiles
    • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Teva Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Hetero Labs Limited Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Sun Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Intas Pharmaceuticals Limited Overview, Products and Services, Strategy and Financial Analysis

31. Onchocerciasis Treatment Market Other Major And Innovative Companies

  • 31.1. Dr. Reddy's Laboratories Inc.
  • 31.2. Cipla Limited
  • 31.3. Endo Inc.
  • 31.4. Lupin Limited
  • 31.5. Instituto de Tecnologia em Imunobiologicos Bio-Manguinhos - Fundacao Oswaldo Cruz (Fiocruz)
  • 31.6. AMGIS Lifescience Ltd.
  • 31.7. Drugs for Neglected Diseases initiative (DNDi)
  • 31.8. Rakshit Drugs Pvt. Ltd.
  • 31.9. Hangzhou Longshine Bio-Tech Co. Ltd.
  • 31.10. OREX Pharma Private Limited
  • 31.11. Angle Bio Pharma Pvt. Ltd.
  • 31.12. Senores Pharmaceuticals Inc.
  • 31.13. Avenacy LLC
  • 31.14. Dolphin Pharma
  • 31.15. Cerata Pharmaceuticals Inc.

32. Global Onchocerciasis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Onchocerciasis Treatment Market

34. Recent Developments In The Onchocerciasis Treatment Market

35. Onchocerciasis Treatment Market High Potential Countries, Segments and Strategies

  • 35.1 Onchocerciasis Treatment Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Onchocerciasis Treatment Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Onchocerciasis Treatment Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer